China Strategy and Implementation— Vision Care

China Strategy and Implementation— Vision Care

Context: China Growth Strategy

  • Scope: Medteryx was engaged to establish a self sustaining Research Institute in China for value-added vision care products
  • Develop China entry strategy including well documented $multi-million business case
  • Provide high level cash-flow budgets.  Including forecasting funds required to support breakeven within 4 years
  • Review and short list potential JV partners
  • Assess and secure approvals from Chinese authorities for legal company structures —WOFE and FICE

Results delivered

Client achieved breakeven position on China investments earlier than plan including:

  • Strategic alliance with a major Ophthalmic Centre/Key Lab University
  • JV commercialisation partnership with a major distributor of ophthalmic products/2000+ points of presence across China
  • Dedicated research facility in Guangzhou
  • Representative office in Beijing for SFDA
  • Cash breakeven ahead of plan.